Lung Tuberculosis with Multi Drug Resistant Risk in Tertiary Hospital in Middle Java

Authors

  • Ratna Wulan Febriyanti Universitas Muhammadiyah Purwokerto
  • Winarto Winarto Universitas Diponegoro
  • Mujahidah Mujahidah Universitas Diponegoro
  • Endang Sri Lestari Universitas DIponegoro
  • Purnomo Hadi Universitas Diponegoro
  • Vincentia Rizke Ciptaningtyas Universitas Diponegoro

DOI:

https://doi.org/10.30595/hmj.v4i2.10352

Keywords:

Risk Factors, pulmonary MDR TB infection, Tuberculosis

Abstract

World TB report from World Health Organization (WHO) in 2017 informed that Indonesia was second country with TB case. Multi Drug Resistance pulmonary infection’s case in Indonesia were 12.000. Kariadi hospital is one of tertiary hospital for pulmonary MDR-TB treatment but, there is no study about risk factor of it yet, so it needed to find risk factors of MDR-TB pulmonary infection in Kariadi hospital. Cross Sectional design using secondary data from Medical Record  from January 1st -  December 31, 2017 with result of Mycobacterium tuberculosis on GeneXpert sputum examination. Bivariate analysis with Chi square test and multivariate analysis was done by multiple logistic regression. The p value was considered significant if <0.05, all analyzes were 2-tailed. Totally 110 patients were obtained during periode, 55 samples for case and 55 samples for control. There were correlation between smoking habit OR = 3,1 (CI 95% 1,1-8,7), malnutrition OR = 2,9 (CI 95% 1,3-6,3), contact with patient with MDR pulmonary TB infection OR = 12,0 (CI 95% 1,5-97,3), past treatment  OR = 81,7(CI 95% 23,4-285,2) and ≥6months past treatment OR = 94,5 (CI 95% 12,1-736,2. Risk factor that could influence together were contact with patient with MDR pulmonary TB infection OR = 34,5 (CI 95% 2,6-464,5), past treatment OR = 39,4 (CI 95% 8,3-186,3) and ≥ 6months past treatment OR = 12,4 (CI 95% 1,3-117,7). Risk factors for the incidence of pulmonary MDR TB infection are past contact with patient with MDR pulmonary TB infection, past treatment  and  ≥ 6months past treatment.

Author Biographies

Ratna Wulan Febriyanti, Universitas Muhammadiyah Purwokerto

Mikrobiologi

Winarto Winarto, Universitas Diponegoro

Mikrobiologi Klinik

Mujahidah Mujahidah, Universitas Diponegoro

Mikrobiologi Klinik

Endang Sri Lestari, Universitas DIponegoro

Mikrobiologi Klinik

Purnomo Hadi, Universitas Diponegoro

Mikrobiologi Klinik

Vincentia Rizke Ciptaningtyas, Universitas Diponegoro

Mikrobiologi Klinik

References

  1. WHO. Global Tuberculosis Report. Geneva: WHO; 2017. p15-16
  2. WHO. Drug Resistant Tuberculosis. Geneva: WHO; 2018.
  3. The End TB PARU Strategy. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis Geneva. 2016.
  4. Blanchard JS. Molecular Mechanisms of Drug Resistance in Tuberculosis. Annu Rev Biochem. 1996;65:215–39.
  5. Liem Nguyen. Antibiotic resistance mechanisms in M. tuberculosis: an update. HHS Public Access. 2016;90(7);1585-1604.
  6. Scott’s, Bailey. Diagnostic Microbiology. Edisi 13. Missouri. Elsevier. 2015.
  7. Whalen Karen. Lippincot Illustrated Riviews: Pharmacology. Edisi 6. Philadelphia. Wolters Kluwers. 2015.
  8. Palomino J, Martin A. Drug Resistance Mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3(3):317– 40.
  9. Mathema B, Jason R, Ted C, Martien B, Marcel B, Judith G, et al. Drivers of Tuberculosis Transmissionon. . The Journal of Infectious Diseases Volume 216, Issue suppl_6. 2017 10 (3). p S644–S653.
  10. Xin-Tong X-WL, Xiao-Yan Shi, Ling Zhou. Prevalence and risk factors of multi-drug resistant tuberculosis in Dailan, China. Journal of International Medical Research. 2017. Vol. 45(6) 1779–1786.
  11. Odone A, Calderon R, Becerra MC, Zhang Z, Contreras CC, Yataco R, et al. Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants. PLoS ONE. 2016. 11(1): e0146642.
  12. A Chijioke, Nsofor, Qi Jiang, Jie Wu, Mingyu Gan, Qingyun Liu, et al. Transmissionon is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China. Shanghai. Scientific Reports. 2017. 08 (07);| 7: 7691.
  13. Grandjean L, Gilman RH, Martin L, Soto E, Castro B, Lopez S, et al. Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study. PLoS Med 2015 12(6): e1001843.
  14. Qianqian L, Wenzhang L, Miao X, Yunfeng C, Xinmiao D, Chengdi W et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Nature. Scientific Reports. 2015. 7: 1090.
  15. Abdulhalik Workicho, Wondwosen Kassahun, Fessahaye Alemseged. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Dovepress. 2017:10 91-96.
  16. Ahmad Ahsan, Saeed Akhtar, Rumina Hasan, Javaid A. Khan c, Syed F. Hussain c, Nadeem Rizvi. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case–control study. International Journal of Mycobacteriology (2012) 137 –142. p138-141.
  17. Rifat Mahfuza, Abul Hasnat, John Hall, Christopher Oldmeadow, Md. Akramul Islam, Ashaque Husain, et al. Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors. Plos One. 2014. doi:10.1371/ journal.pone.0105214. p1-4.
  18. Chuchottaworn, Vipa T, Piamlarp S, Thu Z, Myint T, Duangjai S, et al. Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand. PLoS ONE. 2017.10(10): e0139986
  19. Wei-Bin Li, Yan-Qiu Zhang, Jin Xing, Zhen-Ya Ma1, Ya-Hong Qu1, Xin-Xu Li, et al. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China. Infectious Diseases of Poverty (2015) 4:14.
  20. Qianqian Liu, Wenzhang Li, Miao Xue, Yunfeng Chen, Xinmiao Du, Chengdi Wang, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Scientific Reports. 2017. 7: 1090.
  21. Mesfin YM, Hailemariam D, Biadglign S, Kibret K. Association between HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta-Analysis. PLoS ONE. 2014 9(1): e82235.
  22. WHO. TB-HIV. World Health Organization. 2017.
  23. Onuka O, Ahukanna J, Okebaram C, Dakum P, Agbaje A, Ibeziako V et al. A Case Study of Multi Drug Resistant Tuberculosis (MDR-TB), HIV and Diabetes Mellitus (Dm) Comorbidity: Triple Pathology; Challenges and Prospects. Advances in Infectious Disease. 2017;7,70-79.

Downloads

Published

2021-05-02

How to Cite

Febriyanti, R. W., Winarto, W., Mujahidah, M., Lestari, E. S., Hadi, P., & Ciptaningtyas, V. R. (2021). Lung Tuberculosis with Multi Drug Resistant Risk in Tertiary Hospital in Middle Java. Herb-Medicine Journal: Terbitan Berkala Ilmiah Herbal, Kedokteran Dan Kesehatan, 4(2), 61–67. https://doi.org/10.30595/hmj.v4i2.10352

Issue

Vol. 4 No. 2 (2021): Herb-Medicine Journal April 2021

Section

Research Articles

License

For submission of manuscripts to the Herb-Medicine Journal, the authors must certify that:

I have been authorized by my co-author to submit the manuscript to the Herb-Medicine Journal
I hereby declare, on behalf of myself and my co-authors, that:

The submitted manuscript is original work and has not been published in another peer-reviewed journal or is being considered for publication by another journal. Also, the manuscript does not infringe any existing copyright or other third party rights.
The manuscript does not contain material that may violate the law, slander, or SARA, in any way, violates the terms and conditions contained in the agreement
I/we have taken care that the scientific knowledge and all other statements contained in the manuscript are in accordance with authentic facts and formulas and will not, if followed appropriately, harm the user
No liability shall be assumed by Herb-Medicine Journal, its staff or members of the editorial board for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from the use or operation of any method, product instructions, advertising , or ideas contained in publications by the Herb-Medicine Journal

Authors who publish in the Herb-Medicine Journal certify that all authors have read and agree to the contents of the Cover Letter or the Terms and Conditions. Plagiarism is strictly prohibited, and by submitting a manuscript for publication, the author agrees that the publisher has the legal right to take appropriate action against the author, if plagiarism or false information is found. Once submitted to the Herb-Medicine Journal, authors will not withdraw their manuscript at any stage prior to publication.

The author owns the copyright and grants the journal rights for first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows others to share the work with acknowledgment of the work's authorship and initial publication in this journal.

Authors may enter into separate additional contractual agreements for the non-exclusive distribution of the published journal version of the work (for example, posting it to an institutional repository or publishing it in a book), with acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their websites) prior to and during the submission process, as this can lead to productive exchanges, as well as earlier and larger citation of published work (See The Effects of Open Access).

Untuk pengiriman naskah ke Herb-Medicine Journal, penulis harus menyatakan bahwa:

  1. Saya telah diberikan otorisasi oleh rekan penulis saya untuk memasukkan naskah ke Herb-Medicine Journal
  2. Saya dengan ini menyatakan, atas nama saya dan rekan penulis saya, bahwa:
  • Naskah yang dikirimkan adalah karya asli dan belum pernah diterbitkan dalam jurnal peer-review lain atau sedang dipertimbangkan untuk diterbitkan oleh jurnal lain. Serta, naskah tidak melanggar hak cipta yang ada atau hak pihak ketiga lainnya.
  • Naskah tidak mengandung materi yang mungkin melanggar hukum, memfitnah, atau SARA, dengan cara apa pun, melanggar syarat dan ketentuan yang tercantum dalam perjanjian
  • Saya / kami telah berhati-hati bahwa pengetahuan ilmiah dan semua pernyataan lain yang terkandung dalam naskah sesuai dengan fakta dan formula otentik dan tidak akan, jika diikuti dengan tepat, merugikan pengguna
  • Tidak ada tanggung jawab yang ditanggung oleh Herb-Medicine Journal, stafnya atau anggota dewan editorial untuk setiap cedera dan/atau kerusakan pada orang atau properti sebagai masalah pertanggungjawaban produk, kelalaian atau sebaliknya, atau dari penggunaan atau pengoperasian metode, produk apa pun instruksi, iklan, atau ide yang terkandung dalam publikasi oleh Herb-Medicine Journal

Penulis yang menerbitkan dalam Herb-Medicine Journal menyatakan bahwa semua penulis telah membaca dan menyetujui isi Surat Pengantar atau Syarat dan Ketentuan. Plagiarisme dilarang keras, dan dengan menyerahkan naskah untuk publikasi, penulis setuju bahwa penerbit memiliki hak hukum untuk mengambil tindakan yang pantas terhadap penulis, jika ditemukan plagiarisme atau informasi palsu. Setelah diserahkan ke Herb-Medicine Journal, penulis tidak akan menarik naskah mereka pada tahap apa pun sebelum dipublikasikan.

Penulis memiliki hak cipta dan memberikan hak jurnal untuk publikasi pertama dengan karya yang secara simultan dilisensikan di bawah Lisensi Creative Commons Attribution yang memungkinkan orang lain untuk berbagi karya dengan pengakuan kepengarangan karya dan publikasi awal dalam jurnal ini.

Penulis dapat membuat perjanjian kontrak tambahan yang terpisah untuk distribusi non-eksklusif versi jurnal yang diterbitkan dari karya tersebut (misalnya, mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan atas publikasi awalnya di jurnal ini.

Penulis diizinkan dan didorong untuk memposting pekerjaan mereka secara online (misalnya, dalam repositori institusional atau di situs web mereka) sebelum dan selama proses pengajuan, karena dapat menyebabkan pertukaran yang produktif, serta kutipan yang lebih awal dan lebih besar dari karya yang diterbitkan (Lihat The Effect of Open Access).

Crossref
Scopus
Google Scholar
Europe PMC